MAPT and Alzheimer disease: Finally, we detected 23 H1 and 5 H2 MAPT subhaplotypes in this Croatian cohort, revealing that MAPT haplotype‐tagging polymorphisms and MAPT haplotypes should be further tested as potential genetic biomarkers of AD.